Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Using genetic information to match patients to targeted therapies may improve survival in people with a fast-moving leukemia. Because acute myeloid leukemia is such a fast-moving and deadly cancer,...
Gordon Mills, M.D., Ph.D., the new director of precision oncology at Oregon Health & Science University, outlines a vision for the field. Photo: Gordon Mills, M.D., Ph.D. (OHSU/Kristyna...
Medicine had never seen anything like it before, Brian Druker, M.D., recalled. "These are people who’d been told to get their affairs in order. And now their blood counts are normal," the...
The best available treatment for acute myeloid leukemia is a drug combination established more than 30 years ago. And today less than a third of newly diagnosed AML patients survive beyond five...
Sadik Esener, Ph.D., is the engineer tapped to lead a major new cancer early detection program at the OHSU Knight Cancer Institute. Medical science has come up with only a few ways to detect...